Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | AMGN | VRTX | REGN | BMY |
| Company | Ascendis Pharma ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 134.01 | 312.15 | 425.99 | 980.00 | 44.88 |
| High | 134.98 | 312.15 | 428.32 | 982.58 | 45.32 |
| Low | 131.43 | 309.00 | 424.56 | 973.86 | 44.83 |
| Last | 132.40 | 309.20 | 427.19 | 977.06 | 45.12 |
| Change | -1.06 | -0.95 | +4.41 | +3.26 | +0.18 |
| % Change | -0.79% | -0.31% | +1.04% | +0.33% | +0.40% |
| Volume | 115,180 | 418,958 | 235,714 | 68,121 | 2,923,051 |
| 20-Day Average Volume | 306,010 | 2,863,556 | 1,050,134 | 462,083 | 13,700,330 |
| Previous Close | 133.46 | 310.15 | 422.78 | 973.80 | 44.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 138.44 | 283.88 | 403.49 | 922.93 | 45.84 |
| 20-Day Raw Stochastic | 7.59% | 81.14% | 99.65% | 95.18% | 28.70% |
| 20-Day Relative Strength | 39.84% | 66.26% | 65.22% | 62.06% | 37.99% |
| Weighted Alpha | +43.67 | +37.89 | +26.21 | +29.89 | -32.01 |
| Today's Opinion | 8% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 8% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 48% Buy | 40% Sell | 24% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.97% since 05/06/24 | +3.82% since 05/06/24 | +6.38% since 05/06/24 | +1.92% since 05/06/24 | +2.78% since 05/06/24 |
| Low | 131.43 on 05/13/24 | 298.51 on 05/07/24 | 394.03 on 05/07/24 | 952.14 on 05/08/24 | 43.49 on 05/09/24 |
| High | 137.65 on 05/07/24 | 314.89 on 05/10/24 | 428.32 on 05/13/24 | 982.23 on 05/13/24 | 45.31 on 05/13/24 |
| 1-Month | |||||
| %Chg | -9.14% since 04/12/24 | +16.33% since 04/12/24 | +7.98% since 04/12/24 | +8.00% since 04/12/24 | -6.55% since 04/12/24 |
| Low | 131.43 on 05/13/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 150.19 on 04/15/24 | 322.60 on 05/03/24 | 428.32 on 05/13/24 | 982.23 on 05/13/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | -7.43% since 02/13/24 | +7.04% since 02/13/24 | +2.92% since 02/13/24 | +3.89% since 02/13/24 | -7.37% since 02/13/24 |
| Low | 131.43 on 05/13/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 161.00 on 02/26/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +48.38% since 11/13/23 | +16.58% since 11/13/23 | +13.00% since 11/13/23 | +22.64% since 11/13/23 | -10.03% since 11/13/23 |
| Low | 90.13 on 11/28/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 784.96 on 11/15/23 | 43.33 on 05/02/24 |
| High | 161.00 on 02/26/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,770,575 | 166,375,312 | 109,099,648 | 106,886,240 | 91,097,872 |
| Shares Outstanding, K | 58,224 | 536,435 | 258,053 | 109,762 | 2,027,100 |
| Annual Sales | 288,670,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -521,070,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 104,110,000 | 7,447,000,000 | 2,517,700,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -142,260,000 | -113,000,000 | 968,800,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.54 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 05/02/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.79 | 27.82 | 26.08 | 42.61 |